NR3C2 and heart failure: HHF, hospitalization for heart failure; BMI, body mass index; NYHA, New York Heart Association; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; MRA, mineralocorticoid receptor antagonists; SGLT2i, sodium-glucose cotransporter 2 inhibitors; CaCB, calcium channel blockers